- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Asthma
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1080KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 84KB)
Indacaterol with mometasone – July 2020
Indacaterol with Mometasone: Capsule containing powder for oral inhalation mometasone furoate 80 micrograms with indacaterol 150 micrograms (as acetate) (for use in Breezhaler®), Capsule containing powder for oral inhalation mometasone furoate 160 micrograms with indacaterol 150 micrograms (as acetate) (for use in Breezhaler®), Capsule containing powder for oral inhalation mometasone furoate 320 micrograms with indacaterol 150 micrograms (as acetate) (for use in Breezhaler®); Atectura Breezhaler®
